Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,835 | 3,595 | -12,514 | -13,584 | -13,771 |
| Depreciation Amortization | 25 | 123 | 52 | 42 | 4,083 |
| Income taxes - deferred | -389 | -289 | 90 | -113 | -193 |
| Accounts payable and accrued liabilities | 1,125 | 226 | -808 | 783 | -311 |
| Other Working Capital | -3,270 | 3,666 | -1,822 | 669 | -1,036 |
| Other Operating Activity | 3,383 | 1,238 | 5,445 | 1,776 | 551 |
| Operating Cash Flow | $-9,961 | $8,559 | $-9,557 | $-10,428 | $-10,675 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -111 | -6 | N/A | 6 | -64 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -93 |
| Purchase Of Investment | -8,176 | -35,632 | 0 | N/A | N/A |
| Sale Of Investment | 22,713 | 12,976 | 0 | N/A | N/A |
| Investing Cash Flow | $14,427 | $-22,663 | $0 | $6 | $-157 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,750 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -212 |
| Common Stock Issued | 266 | 1,689 | N/A | 8,117 | 17,795 |
| Common Stock Repurchased | N/A | N/A | N/A | -16 | N/A |
| Other Financing Activity | -2,750 | 13,809 | 5,966 | 520 | 0 |
| Financing Cash Flow | $266 | $15,498 | $5,966 | $8,621 | $17,583 |
| Exchange Rate Effect | 174 | -57 | 36 | -85 | -82 |
| Beginning Cash Position | 3,796 | 2,459 | 6,014 | 7,900 | 1,231 |
| End Cash Position | 8,701 | 3,796 | 2,459 | 6,014 | 7,900 |
| Net Cash Flow | $4,905 | $1,337 | $-3,555 | $-1,886 | $6,669 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,961 | 8,559 | -9,557 | -10,428 | -10,675 |
| Capital Expenditure | -111 | -6 | N/A | N/A | -64 |
| Free Cash Flow | -10,072 | 8,553 | -9,557 | -10,428 | -10,739 |